Routine monitoring of parvovirus B19 (B19V) the first 6 months posttransplantation was performed in 241 seronegative solid organ transplant (SOT) recipients. Incidence rates during the first month and the second to sixth months posttransplantation were 1.2 (95% confidence interval [CI], .33-3.2) and 0.21 (95% CI, .06-.57) per 100 recipients per month, respectively. Of the 6 SOT recipients with positive B19V polymerase chain reaction, 3 (50%) were admitted to hospital and 2 (33%) were treated with intravenous immunoglobulin. Thus, routine monitoring of B19V in seronegative SOT recipients may not be necessary. Targeted screening 1 month posttransplantation and screening upon clinical suspicion could be an alternative strategy.

Original languageEnglish
JournalThe Journal of infectious diseases
Issue number5
Pages (from-to)865-869
Number of pages5
Publication statusPublished - 1 Sept 2021


Dive into the research topics of 'Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients'. Together they form a unique fingerprint.

Cite this